Those who are wary of a potential biotech pullback can utilize a few inverse or bearish ETF options to hedge their positions if Clinton takes office.
For instance, the recently launched Direxion Daily S&P Biotech Bear Shares (NYSEArca: LABD) takes the -3x or -300% daily performance of the biotech sector, ProShares UltraPro Short NASDAQ Biotechnology (NasdaqGM: ZBIO) also tracks the -3x or -300% daily performance of the Nasdaq Biotechnology Index, ProShares Ultrashort Nasdaq Biotechnology (NasdaqGM: BIS) tracks the -2x or -200% daily performance of the biotech space and ProShares UltraShort Health Care (NYSEArca: RXD) follows the -2x or -200% daily performance of the broader healthcare sector.
SEE MORE: Clinton Delivers Poison Pill To Biotech ETFs
What biotech investors do not want to see is a Clinton victory coupled with the Democrats gaining control of the senate.
“Should Trump win on Tuesday, the biotech sector would rally, according to Larry McDonald, head of global macro strategy of ACG Analytics and editor of the Bear Traps Report investment newsletter. However, if Clinton were to win, and Democrats gain control of the Senate, “that’s a big problem for the IBB,” McDonald said in a CNBC interview.
For more information on the biotech sector, visit our biotechnology category.
iShares Nasdaq Biotechnology ETF
